Yangzhou Huitong Technology Corp.,
301601
Scantech
688583
KAISA JiaYun Technology Inc.
300242
Fuchun Technology
300299
Hangzhou Onechance Tech Corp.
300792
CN Stock MarketDetailed Quotes
300272 Canature Health Technology
- 5.74
- -0.08-1.37%
Market Closed Jan 15 15:00 CST
3.31BMarket Cap38.01P/E (TTM)
5.83High5.72Low65.58KlotVolume5.83Open5.82Pre Close37.78MTurnover1.52%Turnover Ratio25.07P/E (Static)577.22MShares8.2752wk High2.93P/B2.47BFloat Cap3.3452wk Low6.98Limit Up431.12MShs Float18.23Historical High4.66Limit Down1.89%Amplitude1.21Historical Low0.22Dividend TTM5.76Avg Price36.84KlotAsk3.83%Div YieldTTM100Lot Size27.22KlotBid
Canature Health Technology News
Canature Health Technology: Canature Health Technology Group Co., Ltd.'s 2024 annual tracking rating report
Kai Neng Health: Accountant\'s Response Report on Kai Neng Health Technology Group Co., Ltd.\'s Audit Letter on Issuance of Convertible Corporate Bonds to Unspecified Targets (2022 Annual Report Data Update)
Kai Neng Health: Response report of the applicant and sponsor agency to the audit inquiry letter on Kai Neng Health Technology Group Co., Ltd. issuing convertible corporate bonds to unspecified targets (2022 annual report data update)
KaiNeng Health: An indicative announcement on responses to the review inquiry letter applying for the issuance of convertible corporate bonds to unspecified targets
Kai Neng Health: Accountant's Response Report to the Audit Inquiry Letter on the Issuance of Convertible Corporate Bonds by Kai Neng Health Technology Group Co., Ltd. to an unspecified target
KaiNeng Health: Response report to the audit inquiry letter on the issuance of convertible corporate bonds by Kaineng Health Technology Group Co., Ltd. to unspecified targets
KaiNeng Health: Response report to the audit inquiry letter on the issuance of convertible corporate bonds by Kaineng Health Technology Group Co., Ltd. to unspecified targets
Kai Neng Health: Accountant's Response Report to the Audit Inquiry Letter on the Issuance of Convertible Corporate Bonds by Kai Neng Health Technology Group Co., Ltd. to an unspecified target
KaiNeng Health: An indicative announcement on responses to the review inquiry letter applying for the issuance of convertible corporate bonds to unspecified targets
Open Energy Health: An empirical analysis report on issuing convertible corporate bonds to unspecified targets
Open Energy Health: On the impact of diluting spot returns on the company's main financial indicators by issuing convertible corporate bonds to unspecified targets and the company's measures and commitments from relevant entities
Open Energy Health: Feasibility analysis report on the use of funds raised by issuing convertible corporate bonds to unspecified targets
Open Energy Health: 2021 Annual Equity Distribution Implementation Notice
Kai Neng Health: Announcement on the completion of the sale of 100% of the shares of Nobukawa Investment
Kaineng Health: Announcement on the progress of the sale of 100% of the shares of Nobukawa Investment
KaiNeng Health: Announcement on the sale of 100% of the shares of Xinchuan Investment and updated data related to related transactions
KaiNeng Health: Announcement on the sale of 100% of the shares and related transactions of Shanghai Xinchuan Investment Management Co., Ltd., a wholly-owned subsidiary
Open Energy Health: Responses from issuers and sponsors to the second round review inquiry letter on the issuance of shares to specific targets (revised draft three times)
Open Energy Health: Responses from issuers and sponsors to review inquiries on issuing shares to specific targets (revised draft three times)
Kai Neng Health: Accountant's Response to the Audit Enquiry Letter on Kai Neng Health Technology Group Co., Ltd.'s Application to Issue Shares to Specific Targets (Second Revised Draft)
